METTL3 and IGF2BP2 stabilize lnc-CTHCC, which binds to hnRNP K and activates YAP1 transcription, thus promoting HCC growth and metastasis (Xia et al., 2022). Here, IGF2BP2 is linked to hepatocellular carcinoma.